Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Le Huong, D.
Right arrow Articles by Piette, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Huong, D.
Right arrow Articles by Piette, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 772-777, Copyright © 1997 by British Society for Rheumatology

ORIGINAL PAPERS

Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies

D Le Huong, B Wechsler, D Vauthier-Brouzes, J Seebacher, G Lefebvre, O Bletry, Y Darbois, P Godeau and JC Piette
Department of Internal Medicine, Groupe Hospitalier Pitie-Salpetriere, Paris, France.

We conducted a prospective study in order to determine planned pregnancy outcome in systemic lupus erythematosus followed in a tertiary referral centre. Pregnancy was authorized if disease was inactive on 20 mg/day prednisone or less for at least 1 yr. Upon the diagnosis of pregnancy, systematic corticosteroids consisting of 10 mg/day prednisone or more were started. In the case of antiphospholipid antibodies, 100 mg/day aspirin was added, replaced by heparin in the pre-partum period. In the case of antiphospholipid syndrome complicated by previous thrombotic events or fetal losses despite aspirin, heparin was prescribed. One woman with a history of atrioventricular block was treated with dexamethasone. Patients were monitored by medical and obstetrical examination, and laboratory tests carried out at least monthly and a quarterly echography. Among 62 pregnancies in 38 women, lupus flare was observed in 27% of the cases, 6% of which occurred in the post-partum period. Flares were moderate except in one renal involvement in a woman with prior diffuse proliferative glomerulonephritis. Therapy was not modified in half of the cases. Pregnancy ended in early spontaneous abortion not related to lupus flare (n = 10), stillbirth (n = 2). induced abortion (n = 2), preterm birth (n = 29) and full-term birth (n = 19). Caesarean section was performed in nine cases. A severe infection occurred in two premature neonates. Another premature neonate was growth retarded. Two children had cutaneous neonatal lupus. No child died, neither had atrioventricular block. Stillbirth and severe prematurity were more common in mothers with antiphospholipid syndrome. After exclusion of early spontaneous and induced abortions, the live birth rate was 96%, that is close to the French general population. The main problem remains a high rate of prematurity, but without maternal or neonatal death.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
M. Motta, A. Tincani, P. L. Meroni, and R. Cimaz
Follow-up of children exposed antenatally to immunosuppressive drugs
Rheumatology, June 1, 2008; 47(suppl_3): iii32 - iii34.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
G Ruiz-Irastorza and M. Khamashta
Lupus and pregnancy: ten questions and some answers
Lupus, May 1, 2008; 17(5): 416 - 420.
[PDF]

Home page
 Rheumatology (Oxford)Home page
D. Le Thi Huong, B. Wechsler, D. Vauthier-Brouzes, P. Duhaut, N. Costedoat, M. R. Andreu, G. Lefebvre, and J.-C. Piette
The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome
Rheumatology, March 1, 2006; 45(3): 332 - 338.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
G Ruiz-Irastorza and M A Khamashta
Evaluation of systemic lupus erythematosus activity during pregnancy
Lupus, September 1, 2004; 13(9): 679 - 682.
[Abstract] [PDF]

Home page
 Obstet GynecolHome page
J. F. Skomsvoll, V. Baste, L. M. Irgens, and M. Ostensen
The Recurrence Risk of Adverse Outcome in the Second Pregnancy in Women With Rheumatic Disease
Obstet. Gynecol., December 1, 2002; 100(6): 1196 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. Cortes-Hernandez, J. Ordi-Ros, F. Paredes, M. Casellas, F. Castillo, and M. Vilardell-Tarres
Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies
Rheumatology, June 1, 2002; 41(6): 643 - 650.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
T Fehr, G Cathomas, C Weber, A Fontana, and A Schaffner
Foetal loss, liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome
Lupus, August 1, 2001; 10(8): 576 - 579.
[Abstract] [PDF]

Home page
 Ann Rheum DisHome page
D L. T. Huong, B Wechsler, D Vauthier-Brouzes, H Beaufils, G Lefebvre, and J-C Piette
Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre
Ann Rheum Dis, June 1, 2001; 60(6): 599 - 604.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.